Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer
The purpose of the study is to evaluate the efficacy and toxicity of different timing of concurrent chemoradiation in the treatment of limited disease status Small-cell lung cancer.
Small Cell Lung Cancer
RADIATION: early CCRT|RADIATION: late CCRT
complete response rate, 6 months
overall survival, 36 months|objective response rate, 6 months|Progression-free survival, 36 months|toxicity by NCI common toxicity version 2.0, 36 months
The purpose of the study is to evaluate the efficacy and toxicity of different timing of concurrent chemoradiation in the treatment of limited disease status Small-cell lung cancer.